APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

T Lymphocyte Activation Antigen CD80

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global T Lymphocyte Activation Antigen CD80 Industry Growth and Trends Forecast to 2032

Report ID 174039430119 December 202595 pages

Choose your research edition.

Industry ResearchT Lymphocyte Activation Antigen CD80 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal T Lymphocyte Activation Antigen CD80 Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal T Lymphocyte Activation Antigen CD80 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Lymphocyte Activation Antigen CD80 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal T Lymphocyte Activation Antigen CD80 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global T Lymphocyte Activation Antigen CD80 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for T Lymphocyte Activation Antigen CD80 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for T Lymphocyte Activation Antigen CD80 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for T Lymphocyte Activation Antigen CD80 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of T Lymphocyte Activation Antigen CD80 include Mologen AG, MedImmune LLC, KAHR medical Ltd, Bristol-Myers Squibb Co, BioAtla LLC and 3SBio Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global T Lymphocyte Activation Antigen CD80 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The T Lymphocyte Activation Antigen CD80 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global T Lymphocyte Activation Antigen CD80 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to T Lymphocyte Activation Antigen CD80.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global T Lymphocyte Activation Antigen CD80 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

T Lymphocyte Activation Antigen CD80 Market by Company

Mologen AG

MedImmune LLC

KAHR medical Ltd

Bristol-Myers Squibb Co

BioAtla LLC

3SBio Inc

T Lymphocyte Activation Antigen CD80 Segment by Type

Abatacept Biosimilar

Abatacept

KAHR-102

CUE-201

Others

T Lymphocyte Activation Antigen CD80 Segment by Application

Autoimmune Disorders

Acute Myelocytic Leukemia

Metabolic Disorders

Others

T Lymphocyte Activation Antigen CD80 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Lymphocyte Activation Antigen CD80 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Lymphocyte Activation Antigen CD80 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Lymphocyte Activation Antigen CD80.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of T Lymphocyte Activation Antigen CD80 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of T Lymphocyte Activation Antigen CD80 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Abatacept Biosimilar Table 2. Major Company of Abatacept Table 3. Major Company of KAHR-102 Table 4. Major Company of CUE-201 Table 5. Major Company of Others Table 6. Global T Lymphocyte Activation Antigen CD80 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (K Units) Table 8. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type (2021-2026) Table 9. Global T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (US$ Million) Table 10. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type (2021-2026) Table 11. Global T Lymphocyte Activation Antigen CD80 Price by Type (2021-2026) & (US$/Unit) Table 12. Global T Lymphocyte Activation Antigen CD80 Sales by Type (2027-2032) & (K Units) Table 13. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type (2027-2032) Table 14. Global T Lymphocyte Activation Antigen CD80 Sales by Type (2027-2032) & (US$ Million) Table 15. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type (2027-2032) Table 16. Global T Lymphocyte Activation Antigen CD80 Price by Type (2027-2032) & (US$/Unit) Table 17. North America T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (K Units) Table 18. North America T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (K Units) Table 20. Europe T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (K Units) Table 24. Latin America T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Type (2021-2026) & (US$ Million) Table 27. T Lymphocyte Activation Antigen CD80 Industry Trends Table 28. T Lymphocyte Activation Antigen CD80 Industry Drivers Table 29. T Lymphocyte Activation Antigen CD80 Industry Opportunities and Challenges Table 30. T Lymphocyte Activation Antigen CD80 Industry Restraints Table 31. Global T Lymphocyte Activation Antigen CD80 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Company (2021-2026) Table 33. Global T Lymphocyte Activation Antigen CD80 Sales by Company (2021-2026) & (K Units) Table 34. Global T Lymphocyte Activation Antigen CD80 Sales Share by Company (2021-2026) Table 35. Global T Lymphocyte Activation Antigen CD80 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global T Lymphocyte Activation Antigen CD80 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global T Lymphocyte Activation Antigen CD80 Major Company Production Sites and Headquarters Table 38. Global T Lymphocyte Activation Antigen CD80 Company, Product Type & Application Table 39. Global T Lymphocyte Activation Antigen CD80 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global T Lymphocyte Activation Antigen CD80 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global T Lymphocyte Activation Antigen CD80 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global T Lymphocyte Activation Antigen CD80 Sales by Region (2021-2026) & (K Units) Table 44. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Region (2021-2026) Table 45. Global T Lymphocyte Activation Antigen CD80 Sales by Region (2021-2026) & (US$ Million) Table 46. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Region (2021-2026) Table 47. Global T Lymphocyte Activation Antigen CD80 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global T Lymphocyte Activation Antigen CD80 Sales by Region (2027-2032) & (K Units) Table 49. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Region (2027-2032) Table 50. Global T Lymphocyte Activation Antigen CD80 Sales by Region (2027-2032) & (US$ Million) Table 51. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Region (2027-2032) Table 52. Global T Lymphocyte Activation Antigen CD80 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global T Lymphocyte Activation Antigen CD80 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (K Units) Table 55. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application (2021-2026) Table 56. Global T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (US$ Million) Table 57. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application (2021-2026) Table 58. Global T Lymphocyte Activation Antigen CD80 Price by Application (2021-2026) & (US$/Unit) Table 59. Global T Lymphocyte Activation Antigen CD80 Sales by Application (2027-2032) & (K Units) Table 60. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application (2027-2032) Table 61. Global T Lymphocyte Activation Antigen CD80 Sales by Application (2027-2032) & (US$ Million) Table 62. Global T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application (2027-2032) Table 63. Global T Lymphocyte Activation Antigen CD80 Price by Application (2027-2032) & (US$/Unit) Table 64. North America T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (K Units) Table 65. North America T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (K Units) Table 67. Europe T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (K Units) Table 71. Latin America T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Application (2021-2026) & (US$ Million) Table 74. Mologen AG Company Information Table 75. Mologen AG Business Overview Table 76. Mologen AG T Lymphocyte Activation Antigen CD80 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Mologen AG T Lymphocyte Activation Antigen CD80 Product Portfolio Table 78. Mologen AG Recent Development Table 79. MedImmune LLC Company Information Table 80. MedImmune LLC Business Overview Table 81. MedImmune LLC T Lymphocyte Activation Antigen CD80 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. MedImmune LLC T Lymphocyte Activation Antigen CD80 Product Portfolio Table 83. MedImmune LLC Recent Development Table 84. KAHR medical Ltd Company Information Table 85. KAHR medical Ltd Business Overview Table 86. KAHR medical Ltd T Lymphocyte Activation Antigen CD80 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. KAHR medical Ltd T Lymphocyte Activation Antigen CD80 Product Portfolio Table 88. KAHR medical Ltd Recent Development Table 89. Bristol-Myers Squibb Co Company Information Table 90. Bristol-Myers Squibb Co Business Overview Table 91. Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD80 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD80 Product Portfolio Table 93. Bristol-Myers Squibb Co Recent Development Table 94. BioAtla LLC Company Information Table 95. BioAtla LLC Business Overview Table 96. BioAtla LLC T Lymphocyte Activation Antigen CD80 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. BioAtla LLC T Lymphocyte Activation Antigen CD80 Product Portfolio Table 98. BioAtla LLC Recent Development Table 99. 3SBio Inc Company Information Table 100. 3SBio Inc Business Overview Table 101. 3SBio Inc T Lymphocyte Activation Antigen CD80 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. 3SBio Inc T Lymphocyte Activation Antigen CD80 Product Portfolio Table 103. 3SBio Inc Recent Development Table 104. North America T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. North America T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026) & (K Units) Table 106. North America T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2021-2026) Table 107. North America T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032) & (K Units) Table 108. North America T Lymphocyte Activation Antigen CD80 Sales Market Share Forecast by Country (2027-2032) Table 109. North America T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. North America T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026) & (US$ Million) Table 111. North America T Lymphocyte Activation Antigen CD80 Market Share by Country (2021-2026) Table 112. North America T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. North America T Lymphocyte Activation Antigen CD80 Market Share Forecast by Country (2027-2032) Table 114. Europe T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Europe T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026) & (K Units) Table 116. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2021-2026) Table 117. Europe T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032) & (K Units) Table 118. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share Forecast by Country (2027-2032) Table 119. Europe T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Europe T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026) & (US$ Million) Table 121. Europe T Lymphocyte Activation Antigen CD80 Market Share by Country (2021-2026) Table 122. Europe T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Europe T Lymphocyte Activation Antigen CD80 Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026) & (K Units) Table 126. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2021-2026) Table 127. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032) & (K Units) Table 128. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026) & (US$ Million) Table 131. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Share by Country (2021-2026) Table 132. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Share Forecast by Country (2027-2032) Table 134. Latin America T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Latin America T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026) & (K Units) Table 136. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2021-2026) Table 137. Latin America T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032) & (K Units) Table 138. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share Forecast by Country (2027-2032) Table 139. Latin America T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Latin America T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026) & (US$ Million) Table 141. Latin America T Lymphocyte Activation Antigen CD80 Market Share by Country (2021-2026) Table 142. Latin America T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Latin America T Lymphocyte Activation Antigen CD80 Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026) & (K Units) Table 146. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2021-2026) Table 147. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032) & (K Units) Table 148. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Share by Country (2021-2026) Table 152. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Share Forecast by Country (2027-2032) Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. T Lymphocyte Activation Antigen CD80 Distributors List Table 157. T Lymphocyte Activation Antigen CD80 Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. T Lymphocyte Activation Antigen CD80 Image Figure 2. Global T Lymphocyte Activation Antigen CD80 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global T Lymphocyte Activation Antigen CD80 Market Size (2021-2032) & (US$ Million) Figure 4. Global T Lymphocyte Activation Antigen CD80 Sales (2021-2032) & (K Units) Figure 5. Abatacept Biosimilar Image Figure 6. Global Abatacept Biosimilar Sales YoY Growth (2021-2032) & (K Units) Figure 7. Abatacept Image Figure 8. Global Abatacept Sales YoY Growth (2021-2032) & (K Units) Figure 9. KAHR-102 Image Figure 10. Global KAHR-102 Sales YoY Growth (2021-2032) & (K Units) Figure 11. CUE-201 Image Figure 12. Global CUE-201 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global T Lymphocyte Activation Antigen CD80 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global T Lymphocyte Activation Antigen CD80 Market Share by Type 2025 VS 2032 Figure 17. North America T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type in 2025 Figure 18. North America T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type in 2025 Figure 19. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type in 2025 Figure 20. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type in 2025 Figure 23. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 T Lymphocyte Activation Antigen CD80 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Autoimmune Disorders Image Figure 30. Global Autoimmune Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 31. Acute Myelocytic Leukemia Image Figure 32. Global Acute Myelocytic Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 33. Metabolic Disorders Image Figure 34. Global Metabolic Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global T Lymphocyte Activation Antigen CD80 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global T Lymphocyte Activation Antigen CD80 Market Share by Application 2025 VS 2032 Figure 39. North America T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application in 2025 Figure 40. North America T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application in 2025 Figure 41. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application in 2025 Figure 42. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application in 2025 Figure 45. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application in 2025 Figure 46. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share in Value by Application in 2025 Figure 49. North America T Lymphocyte Activation Antigen CD80 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America T Lymphocyte Activation Antigen CD80 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America T Lymphocyte Activation Antigen CD80 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America T Lymphocyte Activation Antigen CD80 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe T Lymphocyte Activation Antigen CD80 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe T Lymphocyte Activation Antigen CD80 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe T Lymphocyte Activation Antigen CD80 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe T Lymphocyte Activation Antigen CD80 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America T Lymphocyte Activation Antigen CD80 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America T Lymphocyte Activation Antigen CD80 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America T Lymphocyte Activation Antigen CD80 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America T Lymphocyte Activation Antigen CD80 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. T Lymphocyte Activation Antigen CD80 Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. T Lymphocyte Activation Antigen CD80 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Abatacept Biosimilar
  • Abatacept
  • KAHR-102
  • CUE-201
  • Others
Applications
  • Autoimmune Disorders
  • Acute Myelocytic Leukemia
  • Metabolic Disorders
  • Others
Companies covered
  • Mologen AG
  • MedImmune LLC
  • KAHR medical Ltd
  • Bristol-Myers Squibb Co
  • BioAtla LLC
  • 3SBio Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global T Lymphocyte Activation Antigen CD80 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global T Lymphocyte Activation Antigen CD80 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 T Lymphocyte Activation Antigen CD80 Market by Type
  6. 1.3.1 Abatacept Biosimilar
  7. 1.3.2 Abatacept
  8. 1.3.3 KAHR-102
  9. 1.3.4 CUE-201
  10. 1.3.5 Others
  11. 1.4 Global T Lymphocyte Activation Antigen CD80 Market Size by Type
  12. 1.4.1 Global T Lymphocyte Activation Antigen CD80 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global T Lymphocyte Activation Antigen CD80 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global T Lymphocyte Activation Antigen CD80 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America T Lymphocyte Activation Antigen CD80 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe T Lymphocyte Activation Antigen CD80 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America T Lymphocyte Activation Antigen CD80 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 T Lymphocyte Activation Antigen CD80 Industry Trends
  2. 2.2 T Lymphocyte Activation Antigen CD80 Industry Drivers
  3. 2.3 T Lymphocyte Activation Antigen CD80 Industry Opportunities and Challenges
  4. 2.4 T Lymphocyte Activation Antigen CD80 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by T Lymphocyte Activation Antigen CD80 Revenue (2021-2026)
  2. 3.2 Global Top Players by T Lymphocyte Activation Antigen CD80 Sales (2021-2026)
  3. 3.3 Global Top Players by T Lymphocyte Activation Antigen CD80 Price (2021-2026)
  4. 3.4 Global T Lymphocyte Activation Antigen CD80 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global T Lymphocyte Activation Antigen CD80 Major Company Production Sites & Headquarters
  6. 3.6 Global T Lymphocyte Activation Antigen CD80 Company, Product Type & Application
  7. 3.7 Global T Lymphocyte Activation Antigen CD80 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global T Lymphocyte Activation Antigen CD80 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 T Lymphocyte Activation Antigen CD80 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 T Lymphocyte Activation Antigen CD80 Tier 1, Tier 2, and Tier 3
4 T Lymphocyte Activation Antigen CD80 Regional Status and Outlook
  1. 4.1 Global T Lymphocyte Activation Antigen CD80 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global T Lymphocyte Activation Antigen CD80 Historic Market Size by Region
  3. 4.2.1 Global T Lymphocyte Activation Antigen CD80 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global T Lymphocyte Activation Antigen CD80 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global T Lymphocyte Activation Antigen CD80 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global T Lymphocyte Activation Antigen CD80 Forecasted Market Size by Region
  7. 4.3.1 Global T Lymphocyte Activation Antigen CD80 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global T Lymphocyte Activation Antigen CD80 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global T Lymphocyte Activation Antigen CD80 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 T Lymphocyte Activation Antigen CD80 by Application
  1. 5.1 T Lymphocyte Activation Antigen CD80 Market by Application
  2. 5.1.1 Autoimmune Disorders
  3. 5.1.2 Acute Myelocytic Leukemia
  4. 5.1.3 Metabolic Disorders
  5. 5.1.4 Others
  6. 5.2 Global T Lymphocyte Activation Antigen CD80 Market Size by Application
  7. 5.2.1 Global T Lymphocyte Activation Antigen CD80 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global T Lymphocyte Activation Antigen CD80 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global T Lymphocyte Activation Antigen CD80 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America T Lymphocyte Activation Antigen CD80 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe T Lymphocyte Activation Antigen CD80 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America T Lymphocyte Activation Antigen CD80 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Mologen AG
  2. 6.1.1 Mologen AG Company Information
  3. 6.1.2 Mologen AG Business Overview
  4. 6.1.3 Mologen AG T Lymphocyte Activation Antigen CD80 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Mologen AG T Lymphocyte Activation Antigen CD80 Product Portfolio
  6. 6.1.5 Mologen AG Recent Developments
  7. 6.2 MedImmune LLC
  8. 6.2.1 MedImmune LLC Company Information
  9. 6.2.2 MedImmune LLC Business Overview
  10. 6.2.3 MedImmune LLC T Lymphocyte Activation Antigen CD80 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MedImmune LLC T Lymphocyte Activation Antigen CD80 Product Portfolio
  12. 6.2.5 MedImmune LLC Recent Developments
  13. 6.3 KAHR medical Ltd
  14. 6.3.1 KAHR medical Ltd Company Information
  15. 6.3.2 KAHR medical Ltd Business Overview
  16. 6.3.3 KAHR medical Ltd T Lymphocyte Activation Antigen CD80 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 KAHR medical Ltd T Lymphocyte Activation Antigen CD80 Product Portfolio
  18. 6.3.5 KAHR medical Ltd Recent Developments
  19. 6.4 Bristol-Myers Squibb Co
  20. 6.4.1 Bristol-Myers Squibb Co Company Information
  21. 6.4.2 Bristol-Myers Squibb Co Business Overview
  22. 6.4.3 Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD80 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD80 Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Co Recent Developments
  25. 6.5 BioAtla LLC
  26. 6.5.1 BioAtla LLC Company Information
  27. 6.5.2 BioAtla LLC Business Overview
  28. 6.5.3 BioAtla LLC T Lymphocyte Activation Antigen CD80 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BioAtla LLC T Lymphocyte Activation Antigen CD80 Product Portfolio
  30. 6.5.5 BioAtla LLC Recent Developments
  31. 6.6 3SBio Inc
  32. 6.6.1 3SBio Inc Company Information
  33. 6.6.2 3SBio Inc Business Overview
  34. 6.6.3 3SBio Inc T Lymphocyte Activation Antigen CD80 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 3SBio Inc T Lymphocyte Activation Antigen CD80 Product Portfolio
  36. 6.6.5 3SBio Inc Recent Developments
7 North America by Country
  1. 7.1 North America T Lymphocyte Activation Antigen CD80 Sales by Country
  2. 7.1.1 North America T Lymphocyte Activation Antigen CD80 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026)
  4. 7.1.3 North America T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032)
  5. 7.2 North America T Lymphocyte Activation Antigen CD80 Market Size by Country
  6. 7.2.1 North America T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026)
  8. 7.2.3 North America T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe T Lymphocyte Activation Antigen CD80 Sales by Country
  2. 8.1.1 Europe T Lymphocyte Activation Antigen CD80 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026)
  4. 8.1.3 Europe T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe T Lymphocyte Activation Antigen CD80 Market Size by Country
  6. 8.2.1 Europe T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026)
  8. 8.2.3 Europe T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Country
  2. 9.1.1 Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size by Country
  6. 9.2.1 Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America T Lymphocyte Activation Antigen CD80 Sales by Country
  2. 10.1.1 South America T Lymphocyte Activation Antigen CD80 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026)
  4. 10.1.3 South America T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032)
  5. 10.2 South America T Lymphocyte Activation Antigen CD80 Market Size by Country
  6. 10.2.1 South America T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026)
  8. 10.2.3 South America T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Country
  2. 11.1.1 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size by Country
  6. 11.2.1 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 T Lymphocyte Activation Antigen CD80 Value Chain Analysis
  2. 12.1.1 T Lymphocyte Activation Antigen CD80 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 T Lymphocyte Activation Antigen CD80 Production Mode & Process
  7. 12.2 T Lymphocyte Activation Antigen CD80 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 T Lymphocyte Activation Antigen CD80 Distributors
  10. 12.2.3 T Lymphocyte Activation Antigen CD80 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst